MYTE(MYTE)
MYTE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.16B | $1.21B |
| Low | $1.09B | $1.21B |
| High | $1.24B | $1.21B |
| EBITDA Avg | $13M | $13M |
| Low | $12M | $13M |
| High | $13M | $13M |
| EBIT Avg | $-5M | $-6M |
| Low | $-6M | $-6M |
| High | $-5M | $-6M |
| Net Income Avg | $35M | $15M |
| Low | $34M | $14M |
| High | $35M | $59M |
| EPS Avg | $0.34 | $0.36 |
| Low | $0.34 | $0.14 |
| High | $0.35 | $0.59 |
| Analysts (Rev / EPS) | 4 / 3 | 2 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $301M | $264M | $292M | $779M | $810M |
| Low | $301M | $264M | $292M | $779M | $810M |
| High | $301M | $264M | $292M | $779M | $810M |
| EBITDA Avg | $3M | $3M | $3M | $8M | $9M |
| Low | $3M | $3M | $3M | $8M | $9M |
| High | $3M | $3M | $3M | $8M | $9M |
| EBIT Avg | $-1M | $-1M | $-1M | $-4M | $-4M |
| Low | $-1M | $-1M | $-1M | $-4M | $-4M |
| High | $-1M | $-1M | $-1M | $-4M | $-4M |
| Net Income Avg | $17M | $6M | $23M | $3M | $20M |
| Low | $17M | $6M | $23M | $3M | $20M |
| High | $17M | $6M | $23M | $3M | $20M |
| EPS Avg | $0.14 | $0.05 | $0.18 | $0.02 | $0.16 |
| Low | $0.14 | $0.05 | $0.18 | $0.02 | $0.16 |
| High | $0.14 | $0.05 | $0.18 | $0.02 | $0.16 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 2 / 1 | 2 / 1 |